Non-metabolic role of UCK2 links EGFR-AKT pathway activation to metastasis enhancement in hepatocellular carcinoma
2020 · Oncogenesis · 39 citations
https://doi.org/10.1038/s41389-020-00287-7
X
Xuehua Sun
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
1.2K
Citations
20
h-index
31
i10-index
Xuehua Sun is an academic researcher from Shanghai University of Traditional Chinese Medicine. The author has contributed to research in topics: Hepatitis B Virus Studies & Hepatitis C virus research & Liver Disease Diagnosis and Treatment. The author has an h-index of 20, co-authored 51 publications.
ORCID: 0000-0002-8515-3860Papers by this author
worksQuercetin, a natural flavonoid, protects against hepatic ischemia–reperfusion injury via inhibiting Caspase-8/ASC dependent macrophage pyroptosis
2024 · Journal of Advanced Research · 38 citations
https://doi.org/10.1016/j.jare.2024.05.010
Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1
2023 · Phytomedicine · 28 citations
https://doi.org/10.1016/j.phymed.2023.155183
DJ-1 deficiency attenuates expansion of liver progenitor cells through modulating the inflammatory and fibrogenic niches
2016 · Cell Death and Disease · 25 citations
https://doi.org/10.1038/cddis.2016.161
Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38 pathway: a possible mechanism of hepatitis B virus persistence
2016 · Laboratory Investigation · 18 citations
https://doi.org/10.1038/labinvest.2016.96
Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
2022 · Evidence-based Complementary and Alternative Medicine · 5 citations
https://doi.org/10.1155/2022/6097221
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat